跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 8,694 条关于
“CMT-SORD”
全部
8,694
临床试验
7,343
药物
708
机构
49
资讯
594
11个月前
Applied Therapeutics Faces Regulatory Setback as FDA Meeting Fails to Establish Govorestat Approval Pathway
9个月前
Cycle Pharmaceuticals Acquires Applied Therapeutics in $0.088 Per Share Deal to Advance Rare Disease Pipeline
去年
Applied Therapeutics to Present Extended INSPIRE Trial Data for Govorestat in SORD Deficiency at PNS Annual Meeting
2年前
Govorestat NDA for Classic Galactosemia Faces No FDA Advisory Committee, PDUFA Date on Track
2年前
FDA to Decide on Govorestat for Classic Galactosemia by November 28 After Advisory Committee Not Required
2年前
FDA Extends Review of Govorestat for Classic Galactosemia Treatment
去年
Wearable Tech Shows Promise in Monitoring CMT Disease Progression for Clinical Trials
去年
NMD Pharma's NMD670 Enters Phase 2 Trial for Charcot-Marie-Tooth Disease
2年前
Novartis Secures $1.3 Billion Deal with Chong Kun Dang for HDAC6 Inhibitor Targeting CMT Disease
去年
Applied Therapeutics' Govorestat Nears Potential Approval for Galactosemia and SORD Deficiency
第 1 页,共 60 页
上一页
下一页